Juan Campos, MD
Psychiatry · San Antonio, TXNPI 1023198280
Payments from drug & device makers
Across 45 payments — averaging $19.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$240
- Lundbeck LLC$136
- Johnson & Johnson$103
- Supernus Pharmaceuticals, Inc.$78
- Takeda Pharmaceuticals U.S.A., Inc.$58
- Shire North American Group Inc$53
- plus $228 from 9 others
What the payments were for
- Food & beverage$86997%
- Education$273%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 13 | $240 |
| Lundbeck LLC | 8 | $136 |
| Johnson & Johnson | 4 | $103 |
| Supernus Pharmaceuticals, Inc. | 2 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| Shire North American Group Inc | 3 | $53 |
| Bausch Health US, LLC | 3 | $48 |
| Neuronetics, Inc. | 2 | $34 |
| Corium, LLC | 1 | $29 |
| E.r. Squibb & Sons, L.L.C. | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Ironshore Pharmaceuticals Inc. | 1 | $20 |
| Adlon Therapeutics L.p. | 1 | $17 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
| Avanir Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$896 in reported general payments places this provider in the 65th percentile of 2,238 psychiatry providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clozapine | 31 | $1,486 |
| Eszopiclone | 16 | $335 |
| Clonazepam | 30 | $207 |
| Duloxetine Hcl | 18 | $202 |
| Divalproex Sodium | 11 | $157 |
| Escitalopram Oxalate | 28 | $157 |
| Alprazolam | 15 | $148 |
| Methylphenidate Hcl | 11 | $143 |
| Quetiapine Fumarate | 15 | $130 |
| Sertraline Hcl | 14 | $106 |
| Citalopram HbrCitalopram Hydrobromide | 19 | $42 |
| Trazodone Hcl | 14 | $30 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in San Antonio
- Thomas WeissSan Antonio$1.1M
- Jason MillerSan Antonio$869K
- Nathan JohnstonSan Antonio$435K
- Scott BartleyDallas$42.7M
- David BrownAustin$15.8M
- Rajinder ShiwachDesoto$15.4M
- Darin OkudaDallas$14.7M
- Jason MensahBeaumont$10.3M
- Michael DowningDallas$7.6M
- Rakesh JainLake Jackson$7.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.